Director/PDMR Shareholding

RNS Number : 0276B

AstraZeneca PLC

27 March 2013

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 26 March 2013, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below.  The change in interest relates to the vesting of awards made in March 2010 under the AstraZeneca Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals listed, with the exception of Bahija Jallal, have now become beneficially entitled to 47% of the shares originally awarded.  In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed.  The award made to Bahija Jallal was subject to different performance conditions, the outcome of which resulted in a vesting percentage of 105%. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.  The interests of Bahija Jallal and Mark Mallon are in the Company's American Depositary Shares (ADSs).  One ADS equals one ordinary share.

Name	Shares awarded	Shares vested	Shares withheld	Net shares received	Market price on vesting
Katarina Ageborg	10,275	4,829	0	4,829	3256.5p
Ruud Dobber	20,601	9,682	5,035	4,647	3256.5p
Paul Hudson	5,058	2,377	1,237	1,140	3256.5p
Bahija Jallal	16,431	17,252	6,956	10,296	$49.53
Mark Mallon	18,996	8,928	3,750	5,178	$49.53

A C N Kemp

Company Secretary

27 March 2013

 

END

 

 

RDSUBVOROKAOUAR